Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Paul Matteis is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/02/2024 | RAPP | Buy Now | Rapport Therapeutics | $20.14 | 73.78% | → $35 | Initiates | → Buy | Get Alert |
| 06/27/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $47.82 | 10.83% | $50 → $53 | Maintains | Hold | Get Alert |
| 06/27/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $237.83 | 24.04% | $215 → $295 | Maintains | Buy | Get Alert |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 18.31% | $26 → $21 | Maintains | Hold | Get Alert |
| 04/30/2024 | CTNM | Buy Now | Contineum Therapeutics | $20.15 | 43.92% | → $29 | Initiates | → Buy | Get Alert |
| 03/25/2024 | ANRO | Buy Now | Alto Neuroscience | $15.31 | 109.01% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | DYN | Buy Now | Dyne Therapeutics | $41.47 | -1.13% | $35 → $41 | Maintains | Buy | Get Alert |
| 02/27/2024 | ANRO | Buy Now | Alto Neuroscience | $15.31 | 109.01% | → $32 | Initiates | → Buy | Get Alert |
| 01/05/2024 | NGNE | Buy Now | Neurogene | $41.42 | -25.16% | → $31 | Initiates | → Buy | Get Alert |
| 12/21/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $84.09 | 20.11% | → $101 | Reiterates | Buy → Buy | Get Alert |
| 12/18/2023 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 61.42% | $22 → $20 | Maintains | Hold | Get Alert |
| 12/18/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -1.16% | $141 → $144 | Maintains | Buy | Get Alert |
| 12/18/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $47.82 | 4.56% | $45 → $50 | Maintains | Hold | Get Alert |
| 12/18/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 52.11% | $25 → $27 | Maintains | Hold | Get Alert |
| 12/14/2023 | BIIB | Buy Now | Biogen | $226.40 | 26.77% | $315 → $287 | Maintains | Buy | Get Alert |
| 12/14/2023 | ALEC | Buy Now | Alector | $5.83 | 157.29% | $8 → $15 | Upgrade | Hold → Buy | Get Alert |
| 11/28/2023 | LXEO | Buy Now | Lexeo Therapeutics | $11.11 | 80.02% | → $20 | Initiates | → Buy | Get Alert |
| 11/22/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -24.15% | → $373 | Reiterates | Hold → Hold | Get Alert |
| 11/14/2023 | VTGN | Buy Now | Vistagen Therapeutics | $3.73 | 221.72% | → $12 | Initiates | → Buy | Get Alert |
| 11/07/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -24.15% | $340 → $373 | Maintains | Hold | Get Alert |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $10.81 | 140.52% | → $26 | Initiates | → Buy | Get Alert |
| 09/14/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $237.83 | 0.91% | → $240 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | ALEC | Buy Now | Alector | $5.83 | 37.22% | $10 → $8 | Maintains | Hold | Get Alert |
| 08/07/2023 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 77.56% | $60 → $22 | Downgrade | Buy → Hold | Get Alert |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $84.09 | 28.43% | $118 → $108 | Maintains | Buy | Get Alert |
| 07/25/2023 | BIIB | Buy Now | Biogen | $226.40 | 41.34% | $324 → $320 | Maintains | Buy | Get Alert |
| 06/14/2023 | PEPG | Buy Now | PepGen | $16.55 | 45.02% | → $24 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | ALKS | Buy Now | Alkermes | $24.83 | 32.9% | $31 → $33 | Maintains | Hold | Get Alert |
| 06/06/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -14.2% | $145 → $125 | Maintains | Buy | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -30.86% | $300 → $340 | Maintains | Hold | Get Alert |
| 02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $84.09 | 40.33% | $114 → $118 | Maintains | Buy | Get Alert |
| 02/09/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -38.99% | $289 → $300 | Maintains | Hold | Get Alert |
| 10/30/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -41.23% | → $289 | Maintains | Hold | Get Alert |
| 10/13/2022 | BIIB | Buy Now | Biogen | $226.40 | 32.07% | → $299 | Upgrade | Hold → Buy | Get Alert |
| 09/13/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $260 → $295 | Maintains | Buy | Get Alert |
| 09/12/2022 | BIIB | Buy Now | Biogen | $226.40 | -1.5% | $230 → $223 | Maintains | Hold | Get Alert |
| 08/10/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -46.52% | → $263 | Maintains | Hold | Get Alert |
| 08/09/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $42.90 | 25.87% | $50 → $54 | Maintains | Buy | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $185 → $260 | Maintains | Buy | Get Alert |
| 06/23/2022 | ATHA | Buy Now | Athira Pharma | $3.14 | 59.24% | $36 → $5 | Downgrade | Buy → Hold | Get Alert |
| 06/08/2022 | KALV | Buy Now | KalVista Pharma | $14.55 | 119.93% | $54 → $32 | Maintains | Buy | Get Alert |
| 05/31/2022 | PEPG | Buy Now | PepGen | $16.55 | 45.02% | → $24 | Initiates | → Buy | Get Alert |
| 05/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -51.19% | $222 → $240 | Maintains | Hold | Get Alert |
| 03/08/2022 | ALEC | Buy Now | Alector | $5.83 | 208.75% | $32 → $18 | Downgrade | Buy → Hold | Get Alert |
| 03/08/2022 | BIIB | Buy Now | Biogen | $226.40 | -1.5% | $304 → $223 | Downgrade | Buy → Hold | Get Alert |
| 02/01/2022 | VIGL | Buy Now | Vigil Neuroscience | $3.68 | 552.17% | → $24 | Initiates | → Buy | Get Alert |
| 01/27/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -54.86% | $213 → $222 | Maintains | Hold | Get Alert |
| 10/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -43.67% | $309 → $277 | Maintains | Buy | Get Alert |
| 07/31/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $491.75 | -37.16% | $285 → $309 | Maintains | Buy | Get Alert |
| 12/21/2016 | CDTX | Buy Now | Cidara Therapeutics | $10.99 | 54.69% | → $340 | Initiates | → Outperform | Get Alert |
